High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis

References

• Slaga TJ, Scribner JD. Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst 1973;51:1723–25.
   PubMedGoogle Scholar
• Cameron R, Lee G, Farber E. Chemical mitogens as effective alternatives to partial hepatectomy in the new model for the sequential analysis of hepatocarcinogenesis. Proc Am Assoc Cancer Res 1978;19:56.
   Google Scholar
• Marks F, Bertsch S, Grimm W, Schweizer J. Hyperplastic transformation and tumor promotion in mouse epidermis: possible consequences of disturbances of endogenous mechanism controlling proliferation and differentiation. In: Slaga TJ, Sivak A, Boutwell RK, editors. Carcinogenesis, vol. 2. New York: Raven Press; 1978. pp 97–116.
   Google Scholar
• Argyris TS. Tumor promotion by damage-induced epidermal hyperplasia in the skin of mice. Proc Am Assoc Cancer Res 1979;20:4.
   Google Scholar
• Vasiliev JM, Moizhess TG. Tumorigenicity of sarcoma cells is enhanced by the local environment of implanted foreign body. Int J Cancer 1982;30:525–9.
   PubMed Web of Science ®Google Scholar
• Hamada J, Takeichi N, Okuda F, Ren J, Li X, Hosokawa M, Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn J Cancer Res 1992;83:483–90.
   PubMedGoogle Scholar
• Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1170–1.
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–9.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800–6.
   PubMed Web of Science ®Google Scholar
• Belamaric J. Intrahepatic bile duct carcinoma and C. sinensis infection in Hong Kong. Cancer 1973;31:468–73.
   PubMed Web of Science ®Google Scholar
• Sugihara S, Kojiro M. Pathology of cholangiocarcinoma. In: Okuda K, Ishak KG, editors. Neoplasms of the Liver. Tokyo: Springer; 1987. pp 143–58.
   Google Scholar
• Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000;132:517–24.
   PubMed Web of Science ®Google Scholar
• Okita M, Sakaida I, Hino K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology 2002;62Suppl:24–8.
   PubMedGoogle Scholar
• Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K, Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999;86:589–95.
   PubMed Web of Science ®Google Scholar
• Child CG III, Turcotte JG. Surgery and portal hypertension. Dunphy JE, editor. The liver and portal hypertension. Philadelphia: WB Saunders; 1964. p 50.
   Google Scholar
• Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982;218:474–6.
   PubMed Web of Science ®Google Scholar
• Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1994;73:1149–54.
   PubMed Web of Science ®Google Scholar
• Tarao K, Shimizu A, Ohkawa S, Tamai S. Prediction of the development of hepatocellular carcinoma from HCV-associated liver cirrhosis. J Jpn Soc Int Med 1995;84:1985–91.
   PubMedGoogle Scholar
• Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Hepatocellular carcinoma detected by iodized oil. Radiology 1985;154:10–24.
   Web of Science ®Google Scholar
• Suzuki H, Ohta Y, Takino T, Fujisawa K, Hirayama C. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis double blind trial. Asian Med J 1983;26:423–38.
   Google Scholar
• Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M, Ogawa N. A multicenter randomized control clinical trial of Sho-saiko-to in chronic active hepatitis. Gastroenterol Jpn 1989;24:715–9.
   PubMedGoogle Scholar
• Hino K, Miyakawa H, Takahashi J, Kumada H, Ikeda K, Yoshida A, Histological improvement in inflammation in chronic hepatitis by administration of stronger-seo-minophargen C (SNMC) [in Japanese]. Kan-Tan-Sui 1986;13:797–807.
   Google Scholar
• Bellentani S, Podda M, Tiribelli C, Callea F, Marazzi M, Sodde M, Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial. J Hepatol 1993;19:459–64.
   PubMed Web of Science ®Google Scholar
• Tarao K, Tamai S, Ohkawa S, Miyakawa K, Aoki H, Takashimizu S, The effects of combined drug therapy on the serum alanine aminotransferase level in HCV-associated liver cirrhosis [in Japanese]. Rinsho-to Kenkyu 1998;75:1858–67.
   Google Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression. Chichester, UK: John Wiley; 1989.
   Google Scholar
• Gooley TA, Leisenring W, Cyowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks; new presentation of old estimations. Stat Med 1999;18:695–706.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457–81.
   Web of Science ®Google Scholar
• Mahmood S, Togawa K, Kawanaka M, Niiyama G, Yamada G. An analysis of risk factors for developing hepatocellular carcinoma in a group of hepatitis C patients with stage 3 fibrosis following interferon therapy. Cancer Inform 2008;6:381–7.
   PubMedGoogle Scholar
• Oka H, Tamori A, Kuroki T, Kobayashi M, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61–6.
   PubMed Web of Science ®Google Scholar
• Ishiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S, Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan. Eur J Cancer Prev 2009;18:26–32.
   PubMed Web of Science ®Google Scholar
• Kurokawa M, Hiramatsu N, Oze T, Mochizuki K, Yakushiji T, Kurashige N, Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis. Hepatol Res 2009;39:432–8.
   PubMed Web of Science ®Google Scholar
• Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Kanamori A, Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels. J Hepatol 2009;50:729–35.
   PubMed Web of Science ®Google Scholar
• Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Long-term follow-up of patients with hepatitis C with a normal alanine aminotransferase. J Med Virol 2009;81:446–51.
   PubMed Web of Science ®Google Scholar
• Ferenc S, Bela M, Tamas Z, Lajos B, Zsolt T. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis Col Rect 2005;48:775–86.
   PubMed Web of Science ®Google Scholar
• Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acid Res 1984;12:2137–45.
   PubMed Web of Science ®Google Scholar
• Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature (Lond) 1991;349:431–4.
   PubMed Web of Science ®Google Scholar
• Shiota G, Maeta Y, Mukoyama T, Yanagidani A, Udagawa A, Oyama K, Effect of sho-saiko-to on hepatocarcinogenesis and 8-hydroxy 2′ deoxyguanosine formation. Hepatology 2002;35:1125–33.
   PubMed Web of Science ®Google Scholar
• Nakae D, Kobayashi Y, Akai H, Andoh N, Satoh H, Ohashi K, Involvement of 8-hydroxyguanosine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 1997;57:1281–7.
   PubMed Web of Science ®Google Scholar
• Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994;54:3171–2.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, Kobayashi M, Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 1999;29:1124–30.
   PubMed Web of Science ®Google Scholar